Skip to main content
OpenTrials
Completed

NCT Number: NCT02296866

Assessment of Prokinetic Effects of Erythromycin in Emergency Patients With a Full Stomach

The aims of the study is to assess whether the intravenous infusion of 3 mg/kg erythromycin has a significant gastrokinetic effect leading to empty the stomach in less than 90 minutes in non-fasting patients undergoing emergency trauma surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hopital Edouard Herriot

Lyon, 69003, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Emergency surgery for trauma
  • ASA 1 and 2 patients
  • Full stomach (antral area > 550 mm²)
  • Adult patients

Exclusion criteria

  • No contraindication to erythromycin
  • Extreme emergency surgery (time frame < 90 min between arrival in the service and the start of the surgery)
  • gastroparesis or pathology associated with gastroparesis

Treatment and study plan

Primary outcomes

  1. ultrasonographic measurement of antral area

    Time frame: 30 minutes and immediately before erythromycin infusion, and 30, 60 and 90 min after the start of erythromycin infusion

Sponsors and collaborators

Lead sponsor

Lionel Bouvet

Other

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Nov 20, 2014
Registry last updated
Dec 30, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.